Condition
Fulvestrant
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06784193Phase 1Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
NCT04526028Unknown
Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China
NCT03768479Not ApplicableUnknown
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
Showing all 3 trials